Serving Australia and NZ
1300 543 373
Loading...

AADAC Antibody, FITC conjugated

AADAC Antibody, FITC conjugated

Quick Overview:

Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity.

Product Code: CSB-PA001014LC01HU
Supplier: Cusabio

Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity.
Details
Recombinant Human Arylacetamide deacetylase protein (24-399AA)
Additional Information
Product Name AADAC Antibody, FITC conjugated
Supplier name Cusabio
Group (E.g. Primary) Primary
Concentration 50ug
Clonality Polyclonal
Colour Clear solution
Product Type Antibodies
Conjugate FITC
Size 100ug
Species Reactivity Human
Host Species Rabbit
Applications ELISA
Storage/Storage buffer Preservative: 0.03% Proclin 300<br />Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form Liquid
Purification >95%, Protein G purified
Isotype IgG
Aliases Arylacetamide deacetylase (EC 3.1.1.3), AADAC, DAC
Publications Publication List
Target/Antigen AADAC
Datasheet URL View Datasheet

Images